The relationship between cumulative dose of immunosuppressive agents and COVID‐19‐associated mucormycosis: A multicenter cross‐sectional study

BACKGROUND AND AIMS: Immunosuppressive therapy has a key role in developing coronavirus disease‐2019 (COVID‐19)‐associated mucormycosis. In this study, we investigated the effect of the type and cumulative dose of immunosuppressive agents on COVID‐19‐associated mucormycosis. METHODS: We designed a d...

Descripción completa

Detalles Bibliográficos
Autores principales: Rastkar, Mohsen, SeyedAlinaghi, SeyedAhmad, Asanjarani, Behzad, Siri, Goli, Abdollahi, Hamed, Ghadami, Ladan, Hasibi, Mehrdad, Khodashahi, Rozita, Bagheri, AmirBehzad, Asadollahi‐Amin, Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9682188/
https://www.ncbi.nlm.nih.gov/pubmed/36439042
http://dx.doi.org/10.1002/hsr2.950

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9682188/
https://www.ncbi.nlm.nih.gov/pubmed/36439042
http://dx.doi.org/10.1002/hsr2.950

Ejemplares similares